Pharmaceuticals



< < Back to Main Page

Vendors



Accumetrics (TCT Booth: 2000)

Accumetrics Reviews Meta-analysis Anti-Platelet Therapy After PCI at TCT
September 18, 2009 – Patients’ response to anti-platelet therapy after percutaneous coronary intervention (PCI) and its impact on clinical outcomes will...



AstraZeneca
Tricagrelor Reduces Death, Heart Attacks Without Increased Bleeding Compared to Clopidogrel
September 28, 2009 – New data from the phase III PLATO study showed that ticagrelor (BRILINTA) provided 16 percent reduction of cardiovascular (CV) events...



Eli Lilly and Co. (TCT Booth: 1716)

Effient Helps Reduce Stent Thrombosis
Effient (prasugrel) tablets are indicated for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary...



Sanofi-aventis (TCT Booth: 1610)

Multaq Tablets Treat Atrial Fibrillation and Atrial Flutter
Sanofi-aventis offers Multaq (dronedarone) 400 mg tablets for use in patients with atrial fibrillation (AF) or atrial flutter (AFL). Multaq is the...